Neoadjuvant Chemotherapy Use in Bladder Cancer: A Survey of Current Practice and Opinions

Neoadjuvant Chemotherapy Use in Bladder Cancer: A Survey of Current Practice and Opinions

Objectives. Level 1 evidence supports the use of neoadjuvant chemotherapy (NAC) to improve overall survival in muscle invasive bladder cancer; however utilization rates remain low. The aims of our study were to determine factors associated with NAC use, to more clearly define reasons for low utiliza...

Full description

Bibliographic Details
Main Authors: N. G. Cowan, Y. Chen, T. M. Downs, B. H. Bochner, A. B. Apolo, M. P. Porter, J. C. La Rochelle, C. L. Amling, T. M. Koppie
Format: Article
Language:English
Published: Hindawi Limited 2014-01-01
Series:Advances in Urology
Online Access:http://dx.doi.org/10.1155/2014/746298

Internet

http://dx.doi.org/10.1155/2014/746298

Similar Items